Cargando…
Outcome of Intensive Therapy for Children with Relapsed Acute Myeloid Leukemia: A Single Institution Korean Study
PURPOSE: Approximately 30%–40% of pediatric acute myeloid leukemia (AML) patients relapse. In this study, we analyzed the outcome and prognostic factors of relapsed AML patients who had previously received first-line therapy at our institution. MATERIALS AND METHODS: The study group consisted of 50...
Autores principales: | Lee, Jae Wook, Yoo, Jae Won, Kim, Seongkoo, Jang, Pil-Sang, Chung, Nack-Gyun, Cho, Bin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Cancer Association
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9582462/ https://www.ncbi.nlm.nih.gov/pubmed/34922415 http://dx.doi.org/10.4143/crt.2021.1011 |
Ejemplares similares
-
Efficacy of ponatinib prior to and after allogeneic hematopoietic stem cell transplantation in an adolescent with chronic myeloid leukemia in blast phase
por: Lee, Jae Wook, et al.
Publicado: (2021) -
Rapid resolution of bone marrow necrosis mimicking relapse of pediatric acute lymphoblastic leukemia
por: Lee, Jae Wook, et al.
Publicado: (2020) -
Differing Outcomes of Patients with High Hyperdiploidy and ETV6-RUNX1 Rearrangement in Korean Pediatric Precursor B Cell Acute Lymphoblastic Leukemia
por: Lee, Jae Wook, et al.
Publicado: (2021) -
Prognostic impact of total body irradiation dose in pediatric acute lymphoblastic leukemia patients treated with allogeneic hematopoietic stem cell transplantation in second complete remission
por: Jang, Wonjin, et al.
Publicado: (2022) -
Case report: First report of isolated central nervous system lymphoblastic crisis in a child with chronic myeloid leukemia on dasatinib therapy
por: Jo, Suejung, et al.
Publicado: (2023)